Plasma Proteomics-Based Models for Predicting Therapeutic Benefit and Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
CANCER RESEARCH(2024)
Key words
Biomarkers for Immunotherapy,Immune Checkpoint Blockade,Immune-related Adverse Events,Cancer Immunoediting,Tumor Microenvironment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined